Status: Not yet recruiting
Little Lungs Study
This clinical trial is being done to evaluate the safety and clinical response of late surfactant treatment with budesonide in extremely preterm infants requiring mechanical ventilation at 7-14 days of age.
Participants needed: 24
Trial details
Phase: Phase 1, Phase 2Age: 7-14Biological sex: AllType: InterventionalSponsor: University of Wisconsin, MadisonUpdated: Jan 27, 2026Locations: 2
Eligibility criteria
Gestational age 22 0/7 to 28 6/7 weeks at birth [+3]
Major congenital anomalies including congenital lung malformations and congenita... [+10]